Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 11 | $641,940 |
Sells | 126 | $5,108,688 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
04 Aug 2023 16:50 | TRDA | Entrada Therapeutics Inc | KREHER NERISSA | Chief Medical Officer | 02 Aug 2023 | Sale | 9,280 | 15.0876 | 140,013 | D |
16 Aug 2023 16:32 | TRDA | Entrada Therapeutics Inc | DOSHI DIPAL | President and CEO | 14 Aug 2023 | Sale | 1,000 | 15.6713 | 15,671 | D |
06 Sep 2023 17:07 | TRDA | Entrada Therapeutics Inc | DOWDEN NATHAN J | Chief Operating Officer | 06 Sep 2023 | Sale | 59 | 14.0069 | 826 | D |
06 Sep 2023 17:07 | TRDA | Entrada Therapeutics Inc | DOWDEN NATHAN J | Chief Operating Officer | 06 Sep 2023 | Sale | 913 | 13.4312 | 12,263 | D |
06 Sep 2023 17:08 | TRDA | Entrada Therapeutics Inc | KREHER NERISSA | Chief Medical Officer | 06 Sep 2023 | Sale | 21 | 14 | 294 | D |
06 Sep 2023 17:08 | TRDA | Entrada Therapeutics Inc | KREHER NERISSA | Chief Medical Officer | 06 Sep 2023 | Sale | 871 | 13.4647 | 11,728 | D |
06 Sep 2023 17:11 | TRDA | Entrada Therapeutics Inc | WENTWORTH KORY JAMES | Chief Financial Officer | 06 Sep 2023 | Sale | 46 | 14.03 | 645 | D |
06 Sep 2023 17:11 | TRDA | Entrada Therapeutics Inc | WENTWORTH KORY JAMES | Chief Financial Officer | 06 Sep 2023 | Sale | 904 | 13.4522 | 12,161 | D |
15 Sep 2023 16:21 | TRDA | Entrada Therapeutics Inc | DOSHI DIPAL | President and CEO | 13 Sep 2023 | Sale | 1,000 | 15 | 15,000 | D |
19 Oct 2023 17:27 | TRDA | Entrada Therapeutics Inc | DOSHI DIPAL | President and CEO | 17 Oct 2023 | Sale | 1,000 | 15 | 15,000 | D |
13 Nov 2023 16:35 | TRDA | Entrada Therapeutics Inc | DOSHI DIPAL | President and CEO | 13 Nov 2023 | Sale | 1,000 | 16.23 | 16,230 | D |
22 Dec 2023 16:38 | TRDA | Entrada Therapeutics Inc | DOSHI DIPAL | President and CEO | 20 Dec 2023 | Sale | 1,000 | 15 | 15,000 | D |
26 Dec 2023 16:35 | TRDA | Entrada Therapeutics Inc | WENTWORTH KORY JAMES | Chief Financial Officer | 26 Dec 2023 | Sale | 94 | 16.67 | 1,567 | D |
26 Dec 2023 16:35 | TRDA | Entrada Therapeutics Inc | WENTWORTH KORY JAMES | Chief Financial Officer | 22 Dec 2023 | Sale | 3,677 | 16.4837 | 60,611 | D |
26 Dec 2023 16:35 | TRDA | Entrada Therapeutics Inc | WENTWORTH KORY JAMES | Chief Financial Officer | 22 Dec 2023 | Sale | 6,529 | 15.2417 | 99,513 | D |
26 Dec 2023 16:35 | TRDA | Entrada Therapeutics Inc | WENTWORTH KORY JAMES | Chief Financial Officer | 21 Dec 2023 | Sale | 2,200 | 15.0703 | 33,155 | D |
18 Jan 2024 16:32 | TRDA | Entrada Therapeutics Inc | DOSHI DIPAL | CEO | 16 Jan 2024 | Sale | 1,000 | 15.99 | 15,990 | D |
20 Feb 2024 16:37 | TRDA | Entrada Therapeutics Inc | DOSHI DIPAL | CEO | 15 Feb 2024 | Sale | 1,000 | 15 | 15,000 | D |
08 Mar 2024 16:34 | TRDA | Entrada Therapeutics Inc | DOWDEN NATHAN J | President & COO | 06 Mar 2024 | Sale | 1,826 | 12.3213 | 22,499 | D |
08 Mar 2024 16:36 | TRDA | Entrada Therapeutics Inc | WENTWORTH KORY JAMES | Chief Financial Officer | 06 Mar 2024 | Sale | 4,086 | 12.3067 | 50,285 | D |
21 Mar 2024 16:31 | TRDA | Entrada Therapeutics Inc | KIM PETER S | Director | 21 Mar 2024 | Purchase | 704 | 13.2353 | 9,318 | D |
21 Mar 2024 16:31 | TRDA | Entrada Therapeutics Inc | KIM PETER S | Director | 20 Mar 2024 | Purchase | 1,128 | 12.6604 | 14,281 | D |
21 Mar 2024 16:31 | TRDA | Entrada Therapeutics Inc | KIM PETER S | Director | 19 Mar 2024 | Purchase | 900 | 12.6633 | 11,397 | D |
26 Mar 2024 17:57 | TRDA | Entrada Therapeutics Inc | KIM PETER S | Director | 26 Mar 2024 | Purchase | 2,750 | 13.6397 | 37,509 | D |
26 Mar 2024 17:57 | TRDA | Entrada Therapeutics Inc | KIM PETER S | Director | 25 Mar 2024 | Purchase | 3,180 | 13.356 | 42,472 | D |
26 Mar 2024 17:57 | TRDA | Entrada Therapeutics Inc | KIM PETER S | Director | 22 Mar 2024 | Purchase | 3,118 | 13.759 | 42,901 | D |
01 Apr 2024 16:31 | TRDA | Entrada Therapeutics Inc | KIM PETER S | Director | 28 Mar 2024 | Purchase | 1,512 | 13.7526 | 20,794 | D |
10 Apr 2024 16:35 | TRDA | Entrada Therapeutics Inc | KIM PETER S | Director | 08 Apr 2024 | Purchase | 2,600 | 13.573 | 35,290 | D |
10 May 2024 16:35 | TRDA | Entrada Therapeutics Inc | KIM PETER S | Director | 09 May 2024 | Purchase | 2,200 | 14.2459 | 31,341 | D |
10 May 2024 16:35 | TRDA | Entrada Therapeutics Inc | KIM PETER S | Director | 08 May 2024 | Purchase | 2,276 | 14.0442 | 31,965 | D |
16 May 2024 16:33 | TRDA | Entrada Therapeutics Inc | KIM PETER S | Director | 14 May 2024 | Purchase | 25,000 | 14.5869 | 364,672 | D |
20 May 2024 17:21 | TRDA | Entrada Therapeutics Inc | DOSHI DIPAL | CEO | 17 May 2024 | Sale | 1,200 | 15.1076 | 18,129 | D |
20 May 2024 17:21 | TRDA | Entrada Therapeutics Inc | DOSHI DIPAL | CEO | 16 May 2024 | Sale | 1,800 | 15 | 27,000 | D |
20 May 2024 17:26 | TRDA | Entrada Therapeutics Inc | SETHURAMAN NATARAJAN | Chief Scientific Officer | 20 May 2024 | Sale | 9,675 | 15.188 | 146,944 | D |
20 May 2024 17:26 | TRDA | Entrada Therapeutics Inc | SETHURAMAN NATARAJAN | Chief Scientific Officer | 17 May 2024 | Sale | 8,305 | 15.1416 | 125,751 | D |
20 May 2024 17:26 | TRDA | Entrada Therapeutics Inc | SETHURAMAN NATARAJAN | Chief Scientific Officer | 16 May 2024 | Sale | 1,000 | 15 | 15,000 | D |
14 Jun 2024 16:32 | TRDA | Entrada Therapeutics Inc | DOSHI DIPAL | CEO | 13 Jun 2024 | Sale | 1,000 | 16.1736 | 16,174 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)